BIO Archives - CDR – Chain Drug Review

N.J. governor signs biosimilars legislation

November 10, 2015 by Chain Drug Review BIO, biologic drugs, biologic medicines, BioNJ, biosimilars, Biotechnology Industry Organization, Chris Christie, Debbie Hart, Jim Greenwood Pharmacy, Supplier News

WASHINGTON — New Jersey Gov. Chris Christie has approved legislation to create a pathway for the substitution of interchangeable biologic drugs, drawing praise from the Biotechnology Industry Organization (BIO) and BioNJ, a state biotechnology organization. Christie signed Assembly Bill 2477 into law on Monday, following unanimous passage in the New Jersey Senate and Assembly earlier

California gives green light to substitution of biologics

October 9, 2015 by Chain Drug Review BIO, biologic product, biosimilar, Biotechnology Industry Organization, California Gov. Jerry Brown, interchangeable biologic drugs, Jim Greenwood, Senate Bill 671 Leading Headlines, Pharmacy, Supplier News

WASHINGTON — California Gov. Jerry Brown has approved legislation to create a pathway for the substitution of interchangeable biologic drugs, a move applauded by Biotechnology Industry Organization (BIO). This week, Brown signed Senate Bill 671 into law, following recent passage in both the California Senate and Assembly. The legislation authorizes a pharmacist filling a prescription